A detailed history of Mtm Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mtm Investment Management, LLC holds 4,735 shares of ABBV stock, worth $919,915. This represents 0.35% of its overall portfolio holdings.

Number of Shares
4,735
Previous 4,754 0.4%
Holding current value
$919,915
Previous $865,000 6.13%
% of portfolio
0.35%
Previous 0.37%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$154.79 - $180.76 $2,941 - $3,434
-19 Reduced 0.4%
4,735 $812,000
Q1 2024

Apr 25, 2024

BUY
$159.82 - $182.1 $3,835 - $4,370
24 Added 0.51%
4,754 $865,000
Q4 2023

Jan 16, 2024

BUY
$137.6 - $154.97 $275 - $309
2 Added 0.04%
4,730 $733,000
Q3 2023

Oct 26, 2023

BUY
$133.59 - $154.65 $267 - $309
2 Added 0.04%
4,728 $704,000
Q2 2023

Jul 28, 2023

BUY
$132.51 - $164.9 $265 - $329
2 Added 0.04%
4,726 $636,000
Q1 2023

May 03, 2023

SELL
$144.61 - $166.54 $578 - $666
-4 Reduced 0.08%
4,724 $752,000
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $16,597 - $19,904
-120 Reduced 2.48%
4,728 $764,000
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $2,549 - $2,924
19 Added 0.39%
4,848 $651,000
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $93,856 - $119,322
-682 Reduced 12.38%
4,829 $743,000
Q1 2022

May 02, 2022

BUY
$131.98 - $163.75 $263 - $327
2 Added 0.04%
5,511 $893,000
Q4 2021

Feb 08, 2022

SELL
$107.43 - $135.93 $21,271 - $26,914
-198 Reduced 3.47%
5,509 $746,000
Q3 2021

Oct 22, 2021

SELL
$106.4 - $120.78 $6,596 - $7,488
-62 Reduced 1.07%
5,707 $616,000
Q2 2021

Jul 20, 2021

BUY
$105.21 - $117.21 $210 - $234
2 Added 0.03%
5,769 $650,000
Q1 2021

Apr 19, 2021

BUY
$102.3 - $112.62 $82,146 - $90,433
803 Added 16.18%
5,767 $624,000
Q4 2020

Jan 27, 2021

BUY
$80.49 - $108.67 $399,552 - $539,437
4,964 New
4,964 $532,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mtm Investment Management, LLC Portfolio

Follow Mtm Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mtm Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mtm Investment Management, LLC with notifications on news.